IRIS
FALASCA, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.859
AS - Asia 4.777
EU - Europa 4.553
SA - Sud America 790
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 17.071
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.714
SG - Singapore 1.959
CN - Cina 1.212
IT - Italia 783
IE - Irlanda 679
BR - Brasile 622
RU - Federazione Russa 589
VN - Vietnam 540
SE - Svezia 531
UA - Ucraina 522
GB - Regno Unito 374
DE - Germania 373
TR - Turchia 369
FR - Francia 253
IN - India 211
FI - Finlandia 191
HK - Hong Kong 115
KR - Corea 94
AR - Argentina 79
CA - Canada 75
BD - Bangladesh 46
AT - Austria 44
NL - Olanda 42
MX - Messico 40
PL - Polonia 34
JP - Giappone 32
ID - Indonesia 29
IQ - Iraq 28
ES - Italia 26
EC - Ecuador 25
ZA - Sudafrica 23
PH - Filippine 21
PK - Pakistan 21
BE - Belgio 18
CZ - Repubblica Ceca 17
SA - Arabia Saudita 16
RO - Romania 15
CO - Colombia 14
KE - Kenya 13
LT - Lituania 12
PY - Paraguay 12
VE - Venezuela 12
CH - Svizzera 11
CL - Cile 9
EG - Egitto 9
JO - Giordania 9
TN - Tunisia 9
NP - Nepal 8
PS - Palestinian Territory 8
UY - Uruguay 8
MY - Malesia 7
PE - Perù 7
UZ - Uzbekistan 7
IL - Israele 6
MA - Marocco 6
AU - Australia 5
AZ - Azerbaigian 5
BG - Bulgaria 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
HR - Croazia 5
JM - Giamaica 5
TW - Taiwan 5
CI - Costa d'Avorio 4
EE - Estonia 4
EU - Europa 4
HN - Honduras 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BB - Barbados 3
BY - Bielorussia 3
DK - Danimarca 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
PA - Panama 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
OM - Oman 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
Totale 17.056
Salva come PNG Salva come JPEG
Città #
Singapore 1.458
Chandler 780
San Jose 742
Jacksonville 696
Dublin 662
Dallas 541
Ashburn 503
Princeton 318
Beijing 293
Southend 244
Nanjing 215
Izmir 195
Ho Chi Minh City 169
The Dalles 166
Santa Clara 165
Los Angeles 156
Altamura 141
Hanoi 133
Munich 126
Chieti 111
Dearborn 108
Wilmington 104
Hong Kong 100
New York 98
Cambridge 97
Ann Arbor 87
Tongling 82
Boardman 76
Redondo Beach 69
São Paulo 68
Buffalo 67
Nanchang 65
Moscow 59
Pescara 58
Orem 48
Helsinki 46
Rome 40
Council Bluffs 39
Nuremberg 38
Shenyang 37
Brooklyn 34
Turku 34
Pune 33
Seattle 33
Milan 31
Tokyo 31
Denver 30
Dong Ket 30
Frankfurt am Main 30
Warsaw 30
Tianjin 28
Washington 28
Chennai 27
Hebei 27
Haiphong 26
Toronto 26
Hefei 25
Jiaxing 25
Atlanta 24
Da Nang 24
Kunming 24
Rio de Janeiro 24
Woodbridge 24
Chicago 22
Montreal 22
London 21
Mexico City 21
Changsha 20
Hangzhou 20
Manchester 19
Phoenix 19
Stockholm 19
Brussels 17
Houston 17
Grevenbroich 16
Mumbai 16
Norwalk 16
San Francisco 16
Brasília 15
Baghdad 14
Curitiba 14
Jinan 14
Johannesburg 14
Salvador 14
Vienna 14
Augusta 13
Boston 13
Changchun 13
Espoo 13
Hải Dương 12
Jeddah 12
Nairobi 12
Poplar 12
Brno 11
St Louis 11
Biên Hòa 10
Guarulhos 10
Jakarta 10
Lappeenranta 10
Shanghai 10
Totale 10.400
Salva come PNG Salva come JPEG
Nome #
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 173
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 170
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 169
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 168
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 166
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 162
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 161
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 159
Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features 158
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 157
Acute urinary retention due to HSV-1: a case report 153
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 152
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 151
Metabolic modifications in HIV-infected women 150
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 146
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 144
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 143
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 142
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 141
Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacy 138
Canakinumab in a subgroup of patients with COVID-19 138
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 137
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 136
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 135
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 135
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 133
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 133
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 133
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study 132
Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19 131
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 131
Antiretroviral therapy management and rationalisation of available resources 129
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 128
Relevance of plant lectins in human cell biology and immunology 128
Is the rate of virological failure to cART continuing to decline in recent calendar years? 126
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 125
Assessment of the Vanillin Anti-Inflammatory and Regenerative Potentials in Inflamed Primary Human Gingival Fibroblast 125
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 124
Normal breathing releases SARS-CoV-2 into the air 123
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 122
Different strategies of 25OH vitamin D supplementation in HIV+ subjects. 122
Associations between immune depression and cardiovascular events in HIV infection. 122
Inguinal lymphadenopathy due to Bartonella henselae 120
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 120
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 120
New Therapeutic Options in Mild Moderate COVID-19 Outpatients 119
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 119
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 119
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 118
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 118
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 118
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 117
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 116
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 115
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study 115
Clinical characteristics and cardiovascular implications of the dead patients for COVID-19 114
Periodontitis and cytokine patterns in HIV positive patients 113
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 113
IL-1beta induces alkaline phosphatase in human phagocytes 112
Proteinuria in an African HIV-infected patient: effects of telmisartan. 111
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 111
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV 111
Antimicrobial resistance in intensive care patients hospitalized with SEPSIS: a comparison between the COVID-19 pandemic and pre-pandemic era 110
High dose of erythropoietin in management of interferon/ribavirin induced anemia 110
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 110
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 110
Hypertension in HIV: Management and Treatment 107
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study 107
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 106
Neuroprotective Potential of Bacopa monnieri: Modulation of Inflammatory Signals 106
Approach to COVID-19 in older adults and indications for improving the outcomes 106
Early detection of pleuro-pulmonary tuberculosis by bedside lung ultrasound: A case report and review of literature 105
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 105
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 105
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 104
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 103
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study. 103
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. 102
Correlation between neurocognitive disorders and pattern cytokines in HIV+ patients 102
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 102
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 102
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men 101
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 100
Infected atrial mixoma: a rare cause of fever 100
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 100
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 100
Pidotimod and Immunological Activation in Individuals Infected with HIV 100
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity 99
Interleukin-31: a new cytokine involved in inflammation of the skin 99
Severe HIV-associated hypertriglyceridemia treated with rosuvastatin plus mega-3 fatty acids 99
Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. 99
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. 99
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 99
Prevalence and predictors of malignancies in HIV patients: results of a retrospective multicentric Italian cohort 99
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 99
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 98
Ruolo delle citochine nella patogenesi delle malattie infettive 98
Induction with ribavirin in a relapsing patient with chronic HCV hepatitis. 98
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. 98
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 97
Totale 12.157
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 82 52 69
2021/2022773 27 24 11 157 46 17 30 57 57 28 80 239
2022/20232.316 208 360 139 241 205 439 131 174 252 27 67 73
2023/20241.157 76 50 84 42 100 326 262 58 9 19 12 119
2024/20252.970 187 528 383 112 60 134 97 183 267 209 336 474
2025/20266.255 470 251 876 897 590 370 1.115 405 670 611 0 0
Totale 17.861